Abstract:Aim: The prognosis for gastric cancer (GC) remains grim, underscoring the importance of accurate staging and treatment. Given the potential benefits of using lymph node ratio (LNR) for improved prognostication and treatment planning, it is critical to incorporate examined lymph nodes (ELN) count in an integrated GC staging system. Methods: Patients data from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015 was utilized as training set. The Mantel-Cox survival test was used to calculate chi-square values for 40 LNR segments with a 0.025 interval, defining a novel LNR-based N (rN) classification based on the cutoff points. A revised AJCC (rAJCC) staging system was established by replacing the 8th AJCC N staging with a rN classification. The relationship between the ELN count and prognosis or positive lymph node detection was conducted by using multivariable models. The series of the odds ratios and hazard ratios were fitted with a locally weighted scatterplot smoothing (LOWESS) smoother, and the structural break points were determined by Chow test to clarify an optimal minimum ELN count. The integrated GC staging system incorporated both rAJCC system and the ideal ELN count. Discriminatory ability and prognostic homogeneity of the rAJCC and integrated staging system was compared with AJCC staging system in the SEER validation set (2016-2017), the Cancer Genome Atlas Program (TCGA) database, and the Third Affiliated Hospital of Sun Yat-sen University database. Results: The current study found that LNR and ELN count are both significantly associated with the prognosis of GC patients (HR = 0.98, p < 0.001 and HR = 2.51, p < 0.001). Four peaks of the chi-square value were identified as LNR cut-off points at 0.025, 0.175, 0.45 and 0.6 to define a novel rN stage. In comparison to the 8th AJCC staging system, the rAJCC staging system demonstrated significant prognostic advantages and discriminatory ability in the training set (5-Y OS AUC: 71.7 vs. 73.0; AIC: 57,290.7 vs. 57,054.9). The superiority of the rAJCC staging system was confirmed in all validation sets. Using a LOWESS smoother and Chow test, a threshold ELN count of 30 was determined to maximum improvement in the prognosis of node-negative patients without downgrading due to potential metastasis, while also maximizing the detection efficiency of at least one involved lymph node. The integrated staging system, combining the refined rAJCC classification with an optimized ELN count threshold, has demonstrated superior discriminatory performance compared to the standalone rAJCC or the traditional AJCC system. Conclusion: The development of a novel GC staging system, which integrated the LNR-based N classification and the minimum ELN count, has exhibited superior prognostic accuracy, holding promise as a valuable asset in the clinical management of GC. However, it is crucial to recognize the limitations from the retrospective database, which should be addressed in subsequent analyses.

Proposal of a Novel Subclassification of Pn3b for Improvement the Prognostic Discrimination Ability of Gastric Cancer Patients

The Lymph node ratio optimizes staging in patients with small intestinal neuroendocrine tumors.

The Impact of Total Retrieved Lymph Nodes on Staging and Survival of Patients with Pt3 Gastric Cancer.

A Modified Subclassification to Evaluate the Survival of Patients with N3 Gastric Cancer: an International Database Study

Subclassification of Pn3 Staging Systems for Penile Cancer: Proposal for Modification of the Current TNM Classification.

More than 16 lymphatic metastasis ( pN 3 b ) of resectable gastric cancer ( GC ) associated with inferior prognosis of patients : a large sample single-center retrospective study

[Prognosis Analysis of 310 Patients with Pathological Stage Pn3 Gastric Cancer].

Validity and necessity of sub-classification of N3 in the 7th UICC TNM stage of gastric cancer.

Proposal of a new lymph node staging system for gastric cancer: study from two institutions in China

The Assessment of the Optimal Number of Examined Lymph Nodes and Prognostic Models Based on Lymph Nodes for Predicting Survival Outcome in Patients with Stage N3b Gastric Cancer

Comparison of Three Lymph Node Staging Systems in Predicting Overall Survival for Gastric Cancer Patients after Radical Resection

Incorporation of N0 Stage with Insufficient Numbers of Lymph Nodes into N1 Stage in the Seventh Edition of the TNM Classification Improves Prediction of Prognosis in Gastric Cancer: Results of a Single-Institution Study of 1258 Chinese Patients

A New Pn Staging System Based on Both the Number and Anatomic Location of Metastatic Lymph Nodes in Gastric Cancer

Prognostic Value of a New Staging System Based on the Retrieved Number and Metastatic Rate of LNs in Gastric Cancer with ≤15 Retrieved LNs.

A Substage Increase in The AJCC Classification System Improves Prognostic Prediction in Stage III Gastric Cancer With Insufficient Lymph Nodes Removed

Evaluation of the prognostic value of negative to positive lymph node ratio in gastric cancer: results from multi-institutional cohorts from western and eastern datasets - Cohort study

Proposal for Reclassification of N Staging System in Penile Cancer Patients, Based on Number of Positive Lymph Nodes

Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer

Prognostic Performance of Three Lymph Node Staging Systems in Patients after D2 Lymphadenectomy for Gastric Cancer

Prognostic value of a modified pathological staging system for gastric cancer based on the number of retrieved lymph nodes and metastatic lymph node ratio

To Explore the Effect of NLR and PLR on Prognosis of Rectal Cancer on the basis of T3 substage, and to draw the related nomogram